Cargando…
Tandem CAR-T cells targeting CD70 and B7-H3 exhibit potent preclinical activity against multiple solid tumors
Purpose: Given that heterogeneous expression and variants of antigens on solid tumors are responsible for relapse after chimeric antigen receptor (CAR)-T cell therapy, we hypothesized that combinatorial targeting two tumor-associated antigens would lessen this problem and enhance the antitumor activ...
Autores principales: | Yang, Meijia, Tang, Xin, Zhang, Zongliang, Gu, Lei, Wei, Heng, Zhao, Shasha, Zhong, Kunhong, Mu, Min, Huang, Cheng, Jiang, Caiying, Xu, Jianguo, Guo, Gang, Zhou, Liangxue, Tong, Aiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359081/ https://www.ncbi.nlm.nih.gov/pubmed/32685008 http://dx.doi.org/10.7150/thno.43991 |
Ejemplares similares
-
B7-H3-Targeted CAR-T Cells Exhibit Potent Antitumor Effects on Hematologic and Solid Tumors
por: Zhang, Zongliang, et al.
Publicado: (2020) -
Fn14-targeted BiTE and CAR-T cells demonstrate potent preclinical activity against glioblastoma
por: Li, Gaowei, et al.
Publicado: (2021) -
B7-H3 as a Novel CAR-T Therapeutic Target for Glioblastoma
por: Tang, Xin, et al.
Publicado: (2019) -
AP-64, Encoded by C5orf46, Exhibits Antimicrobial Activity against Gram-Negative Bacteria
por: Zhong, Kunhong, et al.
Publicado: (2021) -
Tumor-associated microglia and macrophages in glioblastoma: From basic insights to therapeutic opportunities
por: Wang, Guoqing, et al.
Publicado: (2022)